Mahmood N, Rabbani S
Front Oncol. 2019; 9:489.
PMID: 31245293
PMC: 6579900.
DOI: 10.3389/fonc.2019.00489.
Aliperti V, Sgueglia G, Aniello F, Vitale E, Fucci L, Donizetti A
Int J Mol Sci. 2019; 20(7).
PMID: 30925677
PMC: 6479754.
DOI: 10.3390/ijms20071548.
Chen D, Zhu B, Lv S, Zhu H, Tang J, Huang C
J Exp Clin Cancer Res. 2017; 36(1):186.
PMID: 29246166
PMC: 5732438.
DOI: 10.1186/s13046-017-0656-4.
Shajahan-Haq A, Boca S, Jin L, Bhuvaneshwar K, Gusev Y, Cheema A
Oncotarget. 2017; 8(57):96865-96884.
PMID: 29228577
PMC: 5722529.
DOI: 10.18632/oncotarget.18292.
Mikles D, Schuchardt B, Bhat V, McDonald C, Farooq A
Arch Biochem Biophys. 2014; 549:1-11.
PMID: 24657079
PMC: 4006273.
DOI: 10.1016/j.abb.2014.03.005.
pH modulates the binding of early growth response protein 1 transcription factor to DNA.
Mikles D, Bhat V, Schuchardt B, Deegan B, Seldeen K, McDonald C
FEBS J. 2013; 280(15):3669-84.
PMID: 23718776
PMC: 3716853.
DOI: 10.1111/febs.12360.
Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer.
Pio R, Jia Z, Baron V, Mercola D
PLoS One. 2013; 8(1):e54096.
PMID: 23342084
PMC: 3544741.
DOI: 10.1371/journal.pone.0054096.
Transcriptional Regulation of EGR1 by EGF and the ERK Signaling Pathway in Prostate Cancer Cells.
Gregg J, Fraizer G
Genes Cancer. 2012; 2(9):900-9.
PMID: 22593802
PMC: 3352154.
DOI: 10.1177/1947601911431885.
A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma.
Bieging K, Fish K, Bondada S, Longnecker R
Blood. 2011; 118(26):6849-59.
PMID: 22039254
PMC: 3245207.
DOI: 10.1182/blood-2011-02-338434.
Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells.
Sauer L, Gitenay D, Vo C, Baron V
Oncogene. 2010; 29(18):2628-37.
PMID: 20190820
PMC: 2865566.
DOI: 10.1038/onc.2010.24.
Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.
Mahalingam D, Natoni A, Keane M, Samali A, Szegezdi E
Br J Cancer. 2010; 102(4):754-64.
PMID: 20087343
PMC: 2837577.
DOI: 10.1038/sj.bjc.6605545.
Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-1/NF-kappaB synergy.
Ma J, Ren Z, Ma Y, Xu L, Zhao Y, Zheng C
J Biol Chem. 2009; 284(50):34600-6.
PMID: 19837667
PMC: 2787322.
DOI: 10.1074/jbc.M109.016246.
Is EGR1 a potential target for prostate cancer therapy?.
Gitenay D, Baron V
Future Oncol. 2009; 5(7):993-1003.
PMID: 19792968
PMC: 2776080.
DOI: 10.2217/fon.09.67.
Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047.
Ignatenko N, Yerushalmi H, Pandey R, Kachel K, Stringer D, Marton L
Cancer Genomics Proteomics. 2009; 6(3):161-75.
PMID: 19487545
PMC: 3586261.
A key role for early growth response-1 and nuclear factor-kappaB in mediating and maintaining GRO/CXCR2 proliferative signaling in esophageal cancer.
Wang B, Khachigian L, Esau L, Birrer M, Zhao X, Parker M
Mol Cancer Res. 2009; 7(5):755-64.
PMID: 19435811
PMC: 6944287.
DOI: 10.1158/1541-7786.MCR-08-0472.
Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases.
Fang M, Wee S, Ronski K, Fan H, Tao S, Lin Q
Genomic Med. 2008; 1(1-2):75-85.
PMID: 18923931
PMC: 2276883.
DOI: 10.1007/s11568-007-9010-9.
hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours.
Nutt J, Foster P, Mellon J, Lunec J
Br J Cancer. 2007; 96(5):762-8.
PMID: 17311025
PMC: 2360087.
DOI: 10.1038/sj.bjc.6603620.
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.
Baron V, Adamson E, Calogero A, Ragona G, Mercola D
Cancer Gene Ther. 2005; 13(2):115-24.
PMID: 16138117
PMC: 2455793.
DOI: 10.1038/sj.cgt.7700896.
Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence.
Krones-Herzig A, Adamson E, Mercola D
Proc Natl Acad Sci U S A. 2003; 100(6):3233-8.
PMID: 12629205
PMC: 152275.
DOI: 10.1073/pnas.2628034100.
Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis.
Moos P, Fitzpatrick F
Proc Natl Acad Sci U S A. 1998; 95(7):3896-901.
PMID: 9520464
PMC: 19934.
DOI: 10.1073/pnas.95.7.3896.